Intel Reports Deep Q1 Loss Driven by $3.9B Mobileye Impairment and $4.1B Restructuring Charges
summarizeSummary
Intel reported a significantly wider net loss in Q1 2026, primarily due to a $3.9 billion goodwill impairment related to Mobileye and $4.1 billion in restructuring charges, despite a modest increase in revenue.
check_boxKey Events
-
Significant Net Loss
Net loss attributable to Intel widened to $3.73 billion in Q1 2026, compared to a net loss of $821 million in Q1 2025.
-
Mobileye Goodwill Impairment
Recognized a $3.9 billion non-cash goodwill impairment charge for the Mobileye reporting unit, driven by a sustained decline in its market capitalization and increased macroeconomic and geopolitical uncertainty.
-
Substantial Restructuring Charges
Incurred $4.07 billion in restructuring and other charges in Q1 2026, a significant increase from $156 million in Q1 2025, primarily from asset impairment.
-
Ireland SCIP Repurchase and New Debt
Completed a $14.2 billion repurchase of Apollo's 49% minority ownership interest in Ireland SCIP in April 2026, funded by existing cash and a new $6.5 billion 364-day senior unsecured term loan facility.
auto_awesomeAnalysis
Intel's Q1 2026 results reveal significant financial challenges, marked by a substantial net loss and a $3.9 billion non-cash goodwill impairment related to its Mobileye unit. This impairment reflects a re-evaluation of Mobileye's value amidst market and geopolitical uncertainties, including the Middle East conflict, which the company explicitly identified as a risk to its Israeli manufacturing operations. The company also recorded $4.07 billion in restructuring and other charges, indicating ongoing efforts to streamline operations but also reflecting significant one-time costs. While core Intel Products segments (CCG and DCAI) showed revenue growth, driven by higher average selling prices, these operational positives are overshadowed by the large losses and charges. The subsequent $14.2 billion repurchase of the Ireland SCIP minority interest, partly financed by a new $6.5 billion term loan, is a major capital allocation decision that will impact future financials. Investors should monitor the ongoing impact of restructuring, the performance of Mobileye, and the geopolitical risks to Intel's global operations.
At the time of this filing, INTC was trading at $85.48 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $335.3B. The 52-week trading range was $18.97 to $70.33. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.